1. Home
  2. ELS vs GH Comparison

ELS vs GH Comparison

Compare ELS & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ELS

Equity Lifestyle Properties Inc.

HOLD

Current Price

$67.11

Market Cap

11.7B

Sector

Real Estate

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$106.64

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELS
GH
Founded
1992
2011
Country
US
US
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
13.3B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
ELS
GH
Price
$67.11
$106.64
Analyst Decision
Buy
Strong Buy
Analyst Count
9
22
Target Price
$70.50
$103.59
AVG Volume (30 Days)
1.8M
1.8M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
3.23%
N/A
EPS Growth
2.55
6.74
EPS
2.01
N/A
Revenue
$1,531,382,000.00
$982,021,000.00
Revenue This Year
$3.71
$35.29
Revenue Next Year
$1.38
$27.42
P/E Ratio
$33.35
N/A
Revenue Growth
0.34
32.88
52 Week Low
$57.63
$34.91
52 Week High
$70.24
$120.74

Technical Indicators

Market Signals
Indicator
ELS
GH
Relative Strength Index (RSI) 65.00 49.95
Support Level $66.76 $102.00
Resistance Level $68.54 $110.46
Average True Range (ATR) 1.27 6.19
MACD 0.18 -0.33
Stochastic Oscillator 75.89 46.62

Price Performance

Historical Comparison
ELS
GH

About ELS Equity Lifestyle Properties Inc.

Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 455 properties across the US with a higher concentration in the Sunbelt region with 38% of the company's properties located in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations with over 70% of the company's properties either being age-restricted or having an average resident age over 55.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: